1. Adams W, Ahrens RC, Chen ML, Christopher D, Chowdhury BA, Conner DP, Dalby R, Fitzgerald K, Hendeles L, Hickey AJ, Hochhaus G, Laube BL, Lucas P, Lee SL, Lyapustina S, Li B, O’connor D, Parikh N, Parkins DA, Peri P, Pitcairn GR, Riebe M, Roy P, Shah T, Singh GJ, Sharp SS, Suman JD, Weda M, Woodcock J, Yu L (2010) Demonstrating bioequivalence of locally acting orally inhaled drug products (OIPS): workshop summary report. J Aerosol Med Pulm Drug Deliv 23:1–29
2. Advair Diskus Product Label.
http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021077s042lbl.pdf
. Assessed 2013
3. Ahrens RC, Bonham AC, Maxwell GA, Weinberger MM (1984) A method for comparing the peak intensity and duration of action of aerosolized bronchodilators using bronchoprovocation with methacholine. Am Rev Respir Dis 129(6):903–906
4. Ahrens RC (2007) Pharmacodynamic testing of test inhaler be: unresolved issues and potential solutions. In: Dalby RN, Byron PR, Peart J, Farr SJ, Suman JD (eds) RDD Europe 2007, vol 1. Davis Healthcare, River Grove, IL, pp 1–10, ISBN: 1-933722-07-X
5. Anderton R, Cuff MT, Frith PA, Cockcroft DW, Morse JLC, Jones NL, Hargreave FE (1979) Bronchial responsiveness to inhaled histamine and exercise. J Allergy Clin Immunol 63:315–320